Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45 | 75 | 1 | 6 | 1 |
| Receivables | 3 | 1 | 3 | 2 | 236 |
| Inventories | 4,078 | 4,098 | 4,118 | 4,118 | 4,128 |
| TOTAL | $4,187 | $4,275 | $4,302 | $4,379 | $4,481 |
| Non-Current Assets | |||||
| PPE Net | 28 | 27 | 31 | 36 | 43 |
| Other Non-Current Assets | 15 | 15 | 15 | 15 | 15 |
| TOTAL | $43 | $42 | $46 | $51 | $58 |
| Total Assets | $4,231 | $4,317 | $4,348 | $4,430 | $4,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,728 | 5,901 | 5,728 | 5,529 | 5,319 |
| Accrued Expenses | 2,327 | 1,980 | 1,776 | 1,590 | 1,557 |
| Other current liabilities | 2,478 | 2,447 | 2,437 | 2,437 | 2,548 |
| TOTAL | $13,828 | $13,143 | $12,696 | $12,112 | $11,756 |
| Non-Current Liabilities | |||||
| Long Term Debt | 65 | 62 | 60 | 57 | 42 |
| Deferred Revenues | 6 | 14 | 14 | 20 | 20 |
| TOTAL | $65 | $62 | $60 | $57 | $42 |
| Total Liabilities | $13,893 | $13,205 | $12,755 | $12,168 | $11,798 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,396 | 28,396 | 28,396 | 28,366 | 25,802 |
| Common Shares | 284 | 284 | 269 | 259 | 258 |
| Retained earnings | -58,539 | -57,476 | -56,697 | -55,693 | -55,028 |
| TOTAL | $-9,663 | $-8,888 | $-8,407 | $-7,738 | $-7,259 |
| Total Liabilities And Equity | $4,231 | $4,317 | $4,348 | $4,430 | $4,539 |